X4 PHARMACEUTICALS, INC (XFOR)
X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
Change in holdings of interested parties/officers - Moshe Magid
Anavex Board Appoints Former SVP of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
Metropolitan Bank Holding Corp. Named to 2026 KBW Bank Honor Roll
Cyngn Announces Date for First Quarter 2026 Financial Results
CDW Declares Quarterly Cash Dividend of $0.630 Per Share
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Royalty Pharma reports first quarter 2026 results
NRG Energy Reports First Quarter 2026 Results and Reaffirms 2026 Financial Guidance
The New York Times Company Reports First-Quarter 2026 Results